Cabenuva ER 600 MG-900 MG susp 6ML
Ended Awarded
- Contract number
- SPE2DX25FVJWW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $38,169
Award facts
- Contract value 100% obligated
- $38,169.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of CABENUVA ER (cabotegravir/rilpivirine) 600 mg-900 mg suspension in 6 mL vials, valued at $38,169.00. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract has an ultimate completion date of October 3, 2025, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly supplies pharmaceutical products and medical commodities to support military and veteran healthcare systems. CABENUVA ER is an antiretroviral medication used in HIV treatment regimens, reflecting the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains. The delivery order aligns with AmerisourceBergen's extensive federal contract portfolio with the Defense Logistics Agency, which demonstrates the company's capability to fulfill federal medical supply requirements through open competition and its position as a key provider within the DLA's global pharmaceutical support infrastructure.
Quick answers
Who was awarded contract SPE2DX25FVJWW?
SPE2DX25FVJWW was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 12, 2025.
How much is contract SPE2DX25FVJWW worth?
The government has obligated $38,169 on SPE2DX25FVJWW.
Is contract SPE2DX25FVJWW an order under another contract?
Yes. SPE2DX25FVJWW is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVJWW competed?
The extent of competition for SPE2DX25FVJWW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award